Shire earnings check Takeda's boxes

With its acquisition by Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) due to close next half, Shire plc (LSE:SHP; NASDAQ:SHPG) reported 5% growth in 2Q18 revenue over 2Q17, outpacing the Japanese pharma's 0.4%

Read the full 319 word article

User Sign In